Skip to main content
Clinical Trials/NCT05111158
NCT05111158UnknownNot Applicable

Multifocal Electro Retinogram Study of Hydroxy Chloroquine Retinopathy in Lupus Nephritis Patients: A Randomized Controlled Clinical Trial."

Minia University1 site in 1 country50 target enrollmentStarted: November 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Analysis of values of R1 or R2 amplitude or Ring Ratio

Study Overview

Brief Summary

The aim of the study to assess the multifocal ERG (mfERG) changes in SLE patients treated with chloroquine in renal patients with comparison to SLE patients without kidney affection.

Detailed Description

Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory

disease that involves different organs and systems. The heterogeneous nature of

the disease represents a great challenge in its diagnosis and management.1 Studies

reported that the percentage of SLE patients demonstrating ocular manifestations

can reach up to 30%.2

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥18 years old.
  • Emmetropic patients with normal fundus.
  • Patients with SLE diagnosed by a rheumatologist with no ocular involvement upon clinical examination.

Exclusion Criteria

  • Patients with history of intraocular surgery as cataract surgery ,retinal detachment surgery, anti-glucoma surgery.
  • Patients with significant media opacity as corneal opacity, cataract.
  • Patients with ocular diseases as glaucoma, uveitis.
  • Patients with systemic diseases as diabetes mellitus, hypertension.

Outcomes

Primary Outcomes

Analysis of values of R1 or R2 amplitude or Ring Ratio

Time Frame: 3 months

Abnormal values of R1 or R2 amplitude or Ring Ratio (R1 / R2, R1 / R3, R1 / R4, R1 / R5) in each of the patient's eyes as abnormal mfERG.

Analysis of mfERG parameters

Time Frame: 3 months

Analysis of N1, P1, N2 in five concentric areas of the macula between the two groups.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Minia University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohamed Salah

Doctor

Minia University

Study Sites (1)

Loading locations...

Similar Trials